Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 1;10(19):4574.
doi: 10.3390/jcm10194574.

Risk Stratification of Patients with Acute Coronary Syndrome

Dávid Bauer  1 , Petr Toušek  1
Affiliations
Review

Risk Stratification of Patients with Acute Coronary Syndrome

Dávid Bauer et al. J Clin Med. .

Abstract

Defining the risk factors affecting the prognosis of patients with acute coronary syndrome (ACS) has been a challenge. Many individual biomarkers and risk scores that predict outcomes during different periods following ACS have been proposed. This review evaluates known outcome predictors supported by clinical data in light of the development of new treatment strategies for ACS patients during the last three decades.

Keywords: acute coronary syndrome; percutaneous coronary intervention; prognosis; risk score; risk stratification.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
GISSI trial—fibrinolysis with streptokinase [69], GUSTO-I trial—fibrinolysis with alteplase (* same year benefit of PCI vs. streptokinase, 142 patients) [23,37], P2Y12—effectiveness of DAPT (Ticlopidine + Acetylsalicylic acid) over anticoagulation after PCI [70], PRAGUE study—benefit of transferring STE-ACS patient to PCI center [71], DES—drug eluting stents approved in Europe (1-year later in the USA) [72], GRACE—validated GRACE risk score [35], DES 2nd generation—higher efficacy everolimus eluting stent [73], Radial access—safer with less vascular complications vs. femoral access [74].
See this image and copyright information in PMC

References

    1. De Lemos J.A., Orrow D.A., Bentley J.H., Omland T.O., Sabatine M.S., McCabe C.H., Hall C., Cannon C.P., Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndrome. N. Engl. J. Med. 2001;345:1014–1021. doi: 10.1056/NEJMoa011053. - DOI - PubMed
    1. Weber M., Bazzino O., Estrada J.L.N., Fuselli J.J., Botto F., De Arenaza D.P., Möllmann H., Nef H.N., Elsässer A., Hamm C.W. N-Terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. J. Am. Coll. Cardiol. 2008;51:1188–1195. doi: 10.1016/j.jacc.2007.11.054. - DOI - PubMed
    1. Collet J.-P., Thiele H., Barbato E., Barthélémy O., Bauersachs J., Bhatt D.L., Dendale P., Dorobantu M., Edvardsen T., Folliguet T., et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 2021;42:1289–1367. doi: 10.1093/eurheartj/ehaa575. - DOI - PubMed
    1. McNamara R.L., Kennedy K.F., Cohen D.J., Diercks D.B., Moscucci M., Ramee S., Wang T.Y., Connolly T., Spertus J.A. Predicting in-hospital mortality in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 2016;68:626–635. doi: 10.1016/j.jacc.2016.05.049. - DOI - PubMed
    1. Thielmann M., Massoudy P., Neuhäuser M., Tsagakis K., Marggraf G., Kamler M., Mann K., Erbel R., Jakob H. Prognostic value of preoperative cardiac troponin I in patients undergoing emergency coronary artery bypass surgery with non-ST-elevation or ST-elevation acute coronary syndromes. Circulation. 2006;114((Suppl. 1)):I-448. doi: 10.1161/CIRCULATIONAHA.105.001057. - DOI - PubMed

LinkOut - more resources